SOST and plasma cell myeloma: We found that the levels of RANKL and sclerostin in the serum of mice injected with high TP–expressing myeloma cells ARP-1 and RPMI8226 were much higher than those in mice injected with low TP–expressing MM.1 S myeloma cells (Supplementary Fig. 4a).